Literature DB >> 21948069

Pharmacodynamic modeling of propofol-induced tidal volume depression in children.

Jin-Oh Hahn1, Sara Khosravi, Maryam Dosani, Guy A Dumont, J Mark Ansermino.   

Abstract

OBJECTIVE: This investigation aimed to develop a pediatric pharmacodynamic model of propofol-induced tidal volume depression towards an ultimate goal of developing a dosing schedule that would preserve spontaneous breathing following a loading dose of propofol.
METHODS: Fifty two ASA 1 and 2 children aged 6-15 year presenting for gastrointestinal endoscopy were enrolled. Subjects were administered a loading dose of 4 mg/kg of propofol intravenously at a constant infusion rate determined by a randomization schedule. Respiratory parameters including tidal volume, respiratory rate, minute volume, and end-tidal CO(2) were recorded at 5 s intervals. Using the predicted plasma concentration, based on the Paedfusor pharmacokinetic model, propofol-induced tidal volume depression was modeled by 3 different approaches (2-stage, pooled, and mixed effects) and results were compared using prediction residual, median percentage errors, median absolute percentage errors, and root-mean-squared normalized errors. The effects of age and body weight as covariates were examined.
RESULTS: Respiratory rate and end-tidal CO(2) did not show clear dependence on the predicted plasma concentration. The pharmacodynamic models for tidal volume derived from different modeling approaches were highly consistent. The 2-stage, pooled, and mixed effects approaches yielded k(e0) of 1.06, 1.24, and 0.72 min(-1); γ of 1.10, 0.83, and 0.93; EC50 of 3.18, 3.44, and 3.00 mcg/ml. Including age and body weight as covariates did not significantly improve the predictive performance of the models.
CONCLUSIONS: A pediatric pharmacodynamic model of propofol-induced tidal volume depression was developed. Models derived from 3 different approaches were shown to be consistent with each other; however, the individual pharmacodynamic parameters exhibited significant inter-individual variability without strong dependence on age and body weight. This would suggest the desirability of adapting the pharmacodynamic model to each subject in real time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948069     DOI: 10.1007/s10877-011-9306-0

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  12 in total

1.  Measuring the predictive performance of computer-controlled infusion pumps.

Authors:  J R Varvel; D L Donoho; S L Shafer
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

2.  'Paedfusor' pharmacokinetic data set.

Authors:  A Absalom; G Kenny
Journal:  Br J Anaesth       Date:  2005-07       Impact factor: 9.166

3.  Prospective evaluation of the time to peak effect of propofol to target the effect site in children.

Authors:  H R Muñoz; P J León; R S Fuentes; G C Echevarría; L I Cortínez
Journal:  Acta Anaesthesiol Scand       Date:  2009-06-03       Impact factor: 2.105

4.  [Pharmacodynamics of propofol in children and adults: comparison based on the auditory evoked potentials index].

Authors:  L I Cortínez; H R Muñoz; R López
Journal:  Rev Esp Anestesiol Reanim       Date:  2006-05

5.  Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers.

Authors:  Erik Olofsen; Merel Boom; Diederik Nieuwenhuijs; Elise Sarton; Luc Teppema; Leon Aarts; Albert Dahan
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

6.  Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.

Authors:  Hernán R Muñoz; Luis I Cortínez; Mauricio E Ibacache; Fernando R Altermatt
Journal:  Anesthesiology       Date:  2004-12       Impact factor: 7.892

7.  The pharmacokinetics of propofol in children using three different data analysis approaches.

Authors:  B K Kataria; S A Ved; H F Nicodemus; G R Hoy; D Lea; M Y Dubois; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1994-01       Impact factor: 7.892

8.  Development and pilot testing of the Neuromuscular Blockade Advisory System.

Authors:  Terence J Gilhuly; Simon R Hutchings; Guy A Dumont; Bernard A Macleod
Journal:  Comput Methods Programs Biomed       Date:  2008-02       Impact factor: 5.428

9.  Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children.

Authors:  C Jeleazcov; H Ihmsen; J Schmidt; C Ammon; H Schwilden; J Schüttler; J Fechner
Journal:  Br J Anaesth       Date:  2008-02-12       Impact factor: 9.166

10.  Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the non-steady state.

Authors:  Thomas Bouillon; Joergen Bruhn; Lucian Radu-Radulescu; Corina Andresen; Carol Cohane; Steven L Shafer
Journal:  Anesthesiology       Date:  2004-02       Impact factor: 7.892

View more
  1 in total

1.  A delayed functional observer/predictor with bounded-error for depth of hypnosis monitoring.

Authors:  Neda Eskandari; Z Jane Wang; Guy A Dumont
Journal:  J Clin Monit Comput       Date:  2016-09-02       Impact factor: 2.502

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.